JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
CALL
Cadence Design Systems
CDNS
$96.8B
| $3.4M | ﹤0.01% |
11,300
+800
| +8% | +$233K |
2023 Q3
5 quarters
|
|
|
CTLP
3602
DELISTED
Cantaloupe
CTLP
| $3.39M | ﹤0.01% |
356,973
+245,579
| +220% | +$2.24M |
2020 Q4
16 quarters
|
|
3603
Lands' End
LE
$304M
| $3.39M | ﹤0.01% |
258,010
+46,094
| +22% | +$723K |
2015 Q4
36 quarters
|
|
3604
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.3B
| $3.39M | ﹤0.01% |
35,645
+1,251
| +4% | +$121K |
2020 Q3
17 quarters
|
|
3605
PUT
Hershey
HSY
$32.2B
| $3.39M | ﹤0.01% |
20,000
-30,000
| -60% | -$5.38M |
2023 Q2
6 quarters
|
|
3606
Sabre
SABR
$795M
| $3.38M | ﹤0.01% |
926,730
-603,343
| -39% | -$2.21M |
2014 Q2
42 quarters
|
|
|
EDN
3607
Edenor
EDN
$873M
| $3.38M | ﹤0.01% |
78,754
-545
| -0.7% | -$18.6K |
2023 Q3
5 quarters
|
|
3608
Keros Therapeutics
KROS
$225M
| $3.38M | ﹤0.01% |
213,431
+182,314
| +586% | +$9.47M |
2020 Q2
18 quarters
|
|
3609
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.08B
| $3.38M | ﹤0.01% |
44,700
+23,306
| +109% | +$1.78M |
2023 Q4
4 quarters
|
|
|
BFS
3610
Saul Centers
BFS
$745M
| $3.37M | ﹤0.01% |
86,974
+31,308
| +56% | +$1.25M |
2013 Q2
46 quarters
|
|
3611
CALL
Crown Castle
CCI
$28.3B
| $3.36M | ﹤0.01% |
37,000
+36,400
| +6,067% | +$3.81M |
2023 Q4
4 quarters
|
|
3612
Intrepid Potash
IPI
$441M
| $3.34M | ﹤0.01% |
152,199
+129,722
| +577% | +$3.27M |
2017 Q4
28 quarters
|
|
3613
PUT
Louisiana-Pacific
LPX
$4.55B
| $3.33M | ﹤0.01% |
32,200
| – | – |
2023 Q3
5 quarters
|
|
3614
Comstock Resources
CRK
$3.75B
| $3.33M | ﹤0.01% |
182,995
+12,657
| +7% | +$175K |
2019 Q1
23 quarters
|
|
3615
PubMatic
PUBM
$839M
| $3.32M | ﹤0.01% |
226,328
+163,979
| +263% | +$2.54M |
2020 Q4
16 quarters
|
|
3616
iShares MSCI Hong Kong ETF
EWH
$1.1B
| $3.32M | ﹤0.01% |
199,524
+41,999
| +27% | +$745K |
2013 Q2
46 quarters
|
|
3617
Edgewise Therapeutics
EWTX
$4.5B
| $3.32M | ﹤0.01% |
124,435
-34,071
| -21% | -$1.08M |
2021 Q2
14 quarters
|
|
3618
HealthStream
HSTM
$943M
| $3.32M | ﹤0.01% |
104,468
+47,264
| +83% | +$1.46M |
2017 Q3
29 quarters
|
|
3619
Vanguard Total Corporate Bond ETF
VTC
$1.64B
| $3.32M | ﹤0.01% |
43,867
+2,003
| +5% | +$155K |
2023 Q1
7 quarters
|
|
|
RYZ
3620
Ryerson Holding Corp
RYZ
$1.33B
| $3.32M | ﹤0.01% |
179,422
+17,771
| +11% | +$399K |
2016 Q1
35 quarters
|
|
3621
CALL
Dynatrace
DT
$17.1B
| $3.32M | ﹤0.01% |
61,000
+31,000
| +103% | +$1.69M |
2024 Q1
3 quarters
|
|
|
WBND
3622
DELISTED
Western Asset Total Return ETF
WBND
| $3.31M | ﹤0.01% |
169,970
-5,323
| -3% | -$107K |
2023 Q3
5 quarters
|
|
3623
PUT
Medtronic
MDT
$110B
| $3.31M | ﹤0.01% |
41,400
-20,000
| -33% | -$1.73M |
2023 Q2
6 quarters
|
|
3624
PUT
International Paper
IP
$16.9B
| $3.29M | ﹤0.01% |
61,200
| – | – |
2021 Q3
13 quarters
|
|
3625
ProShares S&P 500 ex-Energy ETF
SPXE
$86.9M
| $3.29M | ﹤0.01% |
51,976
-14,440
| -22% | -$917K |
2023 Q1
7 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.